In this session, reasons for failure of neuromodulation will be examined and a variety of approaches to regain pain relief in these situations will be discussed. Strategies to be explored include the use of imaging and biomarkers to better predict and optimize outcomes before implant, as well as the use of combined SCS and ITT.
Upon completion of this educational activity, participants should be able to:
- Discuss clinical scenarios involving lack of analgesic benefit from neuromodulation therapies despite best attempts at optimization by the neuromodulation team.
- Recognize the strengths and limitations of SCS and ITT as individual treatments for pain and understand why a combination of these therapies may be helpful.
- Illustrate causes of failure of neuromodulation and discuss the importance of rigorous patient selection for neuromodulation.
- Describe use of imaging biomarkers and objective monitoring of outcomes while trialing neuromodulation therapies.
What to Do When Neuromodulation Therapy Treatment Options Do Not Work
Paul E. Verrills, MD
Role of Combining Spinal Cord Stimulation and Intrathecal Therapy for Pain
Richard L. Rauck, MD
Why Does Neuromodulation Fail?
Michael F. Saulino, MD PhD
Can We Use Imaging and Bio-Markers to Understand and Predict Outcomes of Spinal Cord Stimulation?
Anuj Bhatia, MD
Faculty and Presentations subject to change.
- Advanced Practice Provider Course (PAs, NPs, Nurses): A to Z in Neuromodulation
- Engineering Principles of Spinal Cord Stimulation and Deep Brain Stimulation for Clinicians
- Spinal Cord Stimulation Programming: Basics, Science, Coding
- Controversies in Intrathecal Therapy
- Introduction to Intraoperative Neuromonitoring for Spinal Cord Stimulation